Informations générales (source: ClinicalTrials.gov)
Evaluation of the Protein Intake of the Pregnant Woman According to the Weight Status and in Pregnant Women Operated on Bariatric Surgery (BariaProG)
Interventional
N/A
University Hospital, Clermont-Ferrand (Voir sur ClinicalTrials)
octobre 2018
mars 2020
29 juin 2024
Adequate equipment for lifelong health is essential to ensure healthy health for fetal
development. In France, pregnant women with normal weight have increased protein intake
to 0.78-0.95g / kg / day (ANC 2001). And more recently, AFSSA from 2007 proposed a
recommended nutritional intake of 0.82-1g / kg / d. An increased requirements in the
second and third trimester of 0.25 g / kg / day and 0.46 g / kg / day, respectively,
compared with non-pregnancy values. However, the prevalence of the incompatibility
remains unknown.
In addition, maternal protein intake is inadequate or excessively associated with both
intra-uterine growth retardation and small gestational age weights. Neonatal hypotrophy
is also associated with a risk of chronic diseases in adulthood, including cardiovascular
disease, type 2 diabetes, insulin resistance, high blood pressure and coronary heart
disease.
In obese women or patients undergoing surgery for bariatric surgery, there is currently
no recommendation on the recommended protein intake. Or, maternal obesity plays a role in
the metabolic development of children and bariatric surgery is associated with a major
risk of maternal micronutrient deficiencies and intra-uterine growth retardation.
Prevalence of obesity in France is currently estimated at 17%. Moreover, bariatric
surgery is also fast-growing in France with a number of interventions having tripled
since 2006.
Thus, a better understanding of maternal food needs and applications throughout pregnancy
is needed to improve dietary guidelines and promote fetal, neonatal and long-term health.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Chu Clermont-Ferrand - 63003 - Clermont-Ferrand - France | Lise LACLAUTRE | Contact (sur clinicalTrials) | |||
Critères
Femme
Inclusion Criteria:
-
- Pregnant women from 20 amenorrhea weeks.
- Women aged at least 18 years old.
- Women with BMI ≥ 18.5 and <30 kg / m² = Group 1
- Obese women (BMI ≥ 30 kg / m²) = Group 2
- Women operated on a bariatric surgery (by-pass, sleeve-gastrectomy, gastric band) =
Group 3
-
- Pregnant women from 20 amenorrhea weeks.
- Women aged at least 18 years old.
- Women with BMI ≥ 18.5 and <30 kg / m² = Group 1
- Obese women (BMI ≥ 30 kg / m²) = Group 2
- Women operated on a bariatric surgery (by-pass, sleeve-gastrectomy, gastric band) =
Group 3
-
- Women with BMI <18.5 kg / m²
- Troubles of eating behavior
- Women with gestational diabetes
- Medical history of type 1 or type 2 diabetes
- Multiple pregnancy